BidaskClub lowered shares of Petmed Express (NASDAQ:PETS) from a buy rating to a hold rating in a report published on Saturday morning.
PETS has been the topic of several other research reports. Craig Hallum reiterated a sell rating and set a $32.00 price target (down previously from $38.00) on shares of Petmed Express in a report on Monday, July 9th. ValuEngine downgraded Petmed Express from a sell rating to a strong sell rating in a report on Tuesday, July 24th. Zacks Investment Research downgraded Petmed Express from a buy rating to a hold rating in a report on Tuesday, July 10th. Finally, CL King initiated coverage on Petmed Express in a report on Friday, June 15th. They set a neutral rating on the stock. Three research analysts have rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating to the stock. The stock presently has an average rating of Hold and an average target price of $36.75.
Shares of PETS stock opened at $35.25 on Friday. Petmed Express has a 12 month low of $31.81 and a 12 month high of $57.80. The company has a market cap of $747.37 million, a price-to-earnings ratio of 19.37 and a beta of 0.55.
In other news, Director Robert C. Schweitzer sold 7,500 shares of the stock in a transaction that occurred on Thursday, September 13th. The stock was sold at an average price of $37.00, for a total value of $277,500.00. Following the completion of the sale, the director now directly owns 88,334 shares of the company’s stock, valued at $3,268,358. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 3.70% of the company’s stock.
Institutional investors and hedge funds have recently bought and sold shares of the company. TD Asset Management Inc. bought a new stake in shares of Petmed Express in the second quarter valued at approximately $2,652,000. First Trust Advisors LP boosted its position in shares of Petmed Express by 36.7% in the second quarter. First Trust Advisors LP now owns 76,829 shares of the company’s stock valued at $3,384,000 after acquiring an additional 20,634 shares during the period. Comerica Bank boosted its position in shares of Petmed Express by 15.6% in the second quarter. Comerica Bank now owns 24,938 shares of the company’s stock valued at $1,003,000 after acquiring an additional 3,361 shares during the period. Alps Advisors Inc. boosted its position in shares of Petmed Express by 19.5% in the second quarter. Alps Advisors Inc. now owns 12,289 shares of the company’s stock valued at $559,000 after acquiring an additional 2,007 shares during the period. Finally, Personal Capital Advisors Corp boosted its position in shares of Petmed Express by 17.6% in the second quarter. Personal Capital Advisors Corp now owns 95,369 shares of the company’s stock valued at $4,201,000 after acquiring an additional 14,281 shares during the period. 95.67% of the stock is owned by institutional investors.
About Petmed Express
PetMed Express, Inc engages in the provision of markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. Its non-prescription medications include flea and tick control products, bone and joint care products, vitamins and nutritional supplements, and hygiene products.
Featured Story: Trading Strategy Methods and Types
Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.